Joint Formulary & PAD

Dexamfetamine sulfate - Attention Deficit Hyperactivity Disorder (ADHD) - Adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
CD
NICE
SPC
Restrictions / Comments :
Important

Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.

Patients transitioning from children's services can continue to be managed under existing arrangements

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

PAD Profile

ChemicalSubstance :
Dexamfetamine sulfate
Indication :
Attention Deficit Hyperactivity Disorder (ADHD) - Adults
Group Name :
Keywords :
Attention Deficit Hyperactivity Disorder, shared care
Brand Names Include :
Dexedrine
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Dexamfetamine sulfate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Attention Deficit Hyperactivity Disorder (ADHD) - Adults.

Committee Recommendations (1)

The PCN agreed the Amber Shared Care document below